<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Penumbra <z:hpo ids='HP_0001297'>Stroke</z:hpo> System (<z:chebi fb="17" ids="53277">PSS</z:chebi>) was cleared for use in patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> by the FDA in January 2008 </plain></SENT>
<SENT sid="1" pm="."><plain>We describe our experience of using this new system in <z:hpo ids='HP_0011009'>acute</z:hpo> large vessel occlusive disease following thrombolysis </plain></SENT>
<SENT sid="2" pm="."><plain>Fifteen consecutive patients (mean age 60 years) suffering from <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> were treated with the <z:chebi fb="17" ids="53277">PSS</z:chebi> after intravenous or intra-arterial standard treatment with tissue plasminogen activator (n = 14) or ReoPro (n = 1) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients presented with TIMI 3 before use of the <z:chebi fb="17" ids="53277">PSS</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Carotid stenting (n = 3) and intracranial balloon angioplasty or stenting (n = 2) were performed if indicated </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological evaluation was performed using the NIHSS score and the mRS score </plain></SENT>
<SENT sid="6" pm="."><plain>Initial median NIHSS score in 12 patients with occlusions in the anterior circulation was 15; three patients with basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp> presented with <z:hpo ids='HP_0001259'>coma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Median symptom to procedure start time was 151 min </plain></SENT>
<SENT sid="8" pm="."><plain>In the anterior circulation, 9 of the 12 target vessels were recanalised successfully (TIMI 2 and 3) </plain></SENT>
<SENT sid="9" pm="."><plain>The rate of patients with independent clinical outcome (mRS &lt;/= 2) was 42% </plain></SENT>
<SENT sid="10" pm="."><plain>One patient died 5 days after unsuccessful treatment, one after 28 days and one after 85 days owing to <z:e sem="disease" ids="C0027051" disease_type="Disease or Syndrome" abbrv="MR|mi|AMI">heart attack</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Basilar <z:mp ids='MP_0006134'>artery occlusions</z:mp> could be recanalised in <z:hpo ids='HP_0000001'>all</z:hpo> cases to TIMI 3 </plain></SENT>
<SENT sid="12" pm="."><plain>The clinical result after 90 days was mRS 4 in two cases and mRS 5 in one case </plain></SENT>
<SENT sid="13" pm="."><plain>Symptomatic haemorrhage did not occur </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:chebi fb="17" ids="53277">PSS</z:chebi> can safely be used for recanalisation in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> due to large vessel occlusion, who have already received thrombolysis treatment </plain></SENT>
<SENT sid="15" pm="."><plain>The recanalisation rate was 80% </plain></SENT>
<SENT sid="16" pm="."><plain>Symptomatic haemorrhage did not occur </plain></SENT>
<SENT sid="17" pm="."><plain>Randomized trials may demonstrate that endovascular mechanical thrombectomy improves patient outcome </plain></SENT>
</text></document>